184 related articles for article (PubMed ID: 19189403)
1. Circulating prediagnostic interleukin-6 and C-reactive protein and prostate cancer incidence and mortality.
Stark JR; Li H; Kraft P; Kurth T; Giovannucci EL; Stampfer MJ; Ma J; Mucci LA
Int J Cancer; 2009 Jun; 124(11):2683-9. PubMed ID: 19189403
[TBL] [Abstract][Full Text] [Related]
2. Prediagnostic circulating markers of inflammation and risk of prostate cancer.
Toriola AT; Laukkanen JA; Kurl S; Nyyssönen K; Ronkainen K; Kauhanen J
Int J Cancer; 2013 Dec; 133(12):2961-7. PubMed ID: 23754532
[TBL] [Abstract][Full Text] [Related]
3. Additive effect of interleukin-6 and C-reactive protein (CRP) single nucleotide polymorphism on serum CRP concentration and other cardiovascular risk factors.
Paik JK; Kim OY; Koh SJ; Jang Y; Chae JS; Kim JY; Kim HJ; Hyun YJ; Cho JR; Lee JH
Clin Chim Acta; 2007 May; 380(1-2):68-74. PubMed ID: 17335789
[TBL] [Abstract][Full Text] [Related]
4. Genetic variation across C-reactive protein and risk of prostate cancer.
Markt SC; Rider JR; Penney KL; Schumacher FR; Epstein MM; Fall K; Sesso HD; Stampfer MJ; Mucci LA
Prostate; 2014 Jul; 74(10):1034-42. PubMed ID: 24844401
[TBL] [Abstract][Full Text] [Related]
5. Effects of cholesterol, C-reactive protein, and interleukin-6 on prostate cancer risk in a population of African ancestry.
Tulloch-Reid MK; McFarlane-Anderson N; Bennett FI; Aiken WD; Jackson MD
Cancer Causes Control; 2017 Nov; 28(11):1313-1321. PubMed ID: 28864928
[TBL] [Abstract][Full Text] [Related]
6. The Role of Interleukin-6 Polymorphism (rs1800795) in Prostate Cancer Development and Progression.
Jurečeková J; Drobková H; Šarlinová M; Babušíková E; Sivoňová MK; Matáková T; Kliment J; Halašová E
Anticancer Res; 2018 Jun; 38(6):3663-3667. PubMed ID: 29848725
[TBL] [Abstract][Full Text] [Related]
7. C-reactive protein, interleukin-6, and prostate cancer risk in men aged 65 years and older.
Pierce BL; Biggs ML; DeCambre M; Reiner AP; Li C; Fitzpatrick A; Carlson CS; Stanford JL; Austin MA
Cancer Causes Control; 2009 Sep; 20(7):1193-203. PubMed ID: 19267250
[TBL] [Abstract][Full Text] [Related]
8. Obesity, adipokines, and prostate cancer in a prospective population-based study.
Baillargeon J; Platz EA; Rose DP; Pollock BH; Ankerst DP; Haffner S; Higgins B; Lokshin A; Troyer D; Hernandez J; Lynch S; Leach RJ; Thompson IM
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1331-5. PubMed ID: 16835332
[TBL] [Abstract][Full Text] [Related]
9. Genetic variation in RNASEL associated with prostate cancer risk and progression.
Meyer MS; Penney KL; Stark JR; Schumacher FR; Sesso HD; Loda M; Fiorentino M; Finn S; Flavin RJ; Kurth T; Price AL; Giovannucci EL; Fall K; Stampfer MJ; Ma J; Mucci LA
Carcinogenesis; 2010 Sep; 31(9):1597-603. PubMed ID: 20576793
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 receptor gene, plasma C-reactive protein, and diabetes risk in women.
Qi L; Rifai N; Hu FB
Diabetes; 2009 Jan; 58(1):275-8. PubMed ID: 18852330
[TBL] [Abstract][Full Text] [Related]
11. The increased plasma C-reactive protein and interleukin-6 levels in patients undergoing coronary artery bypass grafting surgery are associated with the interleukin-6-174G > C gene polymorphism.
Wypasek E; Undas A; Sniezek-Maciejewska M; Kapelak B; Plicner D; Stepien E; Sadowski J
Ann Clin Biochem; 2010 Jul; 47(Pt 4):343-9. PubMed ID: 20592333
[TBL] [Abstract][Full Text] [Related]
12. [Long term effect of autoadjusting positive airway pressure on C-reactive protein and interleukin-6 in men with obstructive sleep apnoea syndrome].
Drummond M; Winck J; Guimarães J; Santos AC; Almeida J; Marques J
Arch Bronconeumol; 2009 Dec; 45(12):577-84. PubMed ID: 19552994
[TBL] [Abstract][Full Text] [Related]
13. Association between prediagnostic biomarkers of inflammation and endothelial function and cancer risk: a nested case-control study.
Touvier M; Fezeu L; Ahluwalia N; Julia C; Charnaux N; Sutton A; Méjean C; Latino-Martel P; Hercberg S; Galan P; Czernichow S
Am J Epidemiol; 2013 Jan; 177(1):3-13. PubMed ID: 23171880
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory serum markers and risk and severity of prostate cancer: The PROCA-life study.
Stikbakke E; Richardsen E; Knutsen T; Wilsgaard T; Giovannucci EL; McTiernan A; Eggen AE; Haugnes HS; Thune I
Int J Cancer; 2020 Jul; 147(1):84-92. PubMed ID: 31583707
[TBL] [Abstract][Full Text] [Related]
15. Association of -174 G>C interleukin-6 gene polymorphism with interleukin-6 and c-reactive protein levels and obesity: A case-control study among people/residents of Western Indonesia.
Pramudji H; Demes CM; Dewi K; Tasmini T; Ahmad HS
Med J Malaysia; 2019 Oct; 74(5):400-404. PubMed ID: 31649216
[TBL] [Abstract][Full Text] [Related]
16. Role of interleukin-6 gene polymorphisms in the development of prostate cancer.
Chen CH; Gong M; Yi QT; Guo JH
Genet Mol Res; 2015 Oct; 14(4):13370-4. PubMed ID: 26535651
[TBL] [Abstract][Full Text] [Related]
17. Associations of circulating C-reactive protein and interleukin-6 with survival in women with and without cancer: findings from the British Women's Heart and Health Study.
Heikkilä K; Ebrahim S; Rumley A; Lowe G; Lawlor DA
Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1155-9. PubMed ID: 17548678
[TBL] [Abstract][Full Text] [Related]
18. Correlation between interleukin-6 promoter and C-reactive protein (CRP) polymorphisms and CRP levels with the Mainz Severity Score Index for Fabry disease.
Altarescu G; Chicco G; Whybra C; Delgado-Sanchez S; Sharon N; Beck M; Elstein D
J Inherit Metab Dis; 2008 Feb; 31(1):117-23. PubMed ID: 18172744
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study.
Pradhan AD; Manson JE; Rossouw JE; Siscovick DS; Mouton CP; Rifai N; Wallace RB; Jackson RD; Pettinger MB; Ridker PM
JAMA; 2002 Aug; 288(8):980-7. PubMed ID: 12190368
[TBL] [Abstract][Full Text] [Related]
20. Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women.
Fernandez-Real JM; Vayreda M; Richart C; Gutierrez C; Broch M; Vendrell J; Ricart W
J Clin Endocrinol Metab; 2001 Mar; 86(3):1154-9. PubMed ID: 11238501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
